A. Tutela

Survey of ophthalmology · 2009

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from A. Tutela's perspective

Ordered by how strongly the researchers A. Tutela trusts endorse each paper. Same corpus, a different order for every researcher.

  1. VEGF receptor signalling ? in control of vascular function (Nature reviews. Molecular cell biology)
  2. Tight junction proteins. (Progress in Biophysics and Molecular Biology)
  3. A central role for inflammation in the pathogenesis of diabetic retinopathy (The FASEB Journal)
  4. Vascular endothelial growth factors and angiogenesis in eye disease. (Progress in retinal and eye research)
  5. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. (Glycobiology)
  6. Intravitreal triamcinolone for refractory diabetic macular edema. (Ophthalmology (Rochester, Minn.))
  7. Pegaptanib for neovascular age-related macular degeneration. (New England Journal of Medicine)
  8. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. (Ophthalmology (Rochester, Minn.))
  9. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. (Progress in Neuro-psychopharmacology and Biological Psychiatry)
  10. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. (Clinical science)

Their papers